Concepedia

Fankai Meng

FM

31

Publications

2.1K

Citations

22

H-Index

2009

Active since

Affiliations

Huazhong University of Science and Technology(Current)

Tongji Hospital

Jilin University

Union Hospital

Hubei Provincial Center for Disease Control and Prevention

Fankai Meng is an author at Huazhong University of Science and Technology specializing in medicine, cell biology, and tumor biology.

ORCID

Top concepts

Publications per year

2009–2024

31

Publications

31

Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): A multicenter, single-blind, randomized controlled trial

Yang Cao, Jia Wei, Liang Zou et al. · Journal of Allergy and Clinical Immunology · 2020 · 475 citations · Full text

Elevated serum levels of S100A8/A9 and HMGB1 at hospital admission are correlated with inferior clinical outcomes in COVID-19 patients

Liting Chen, Xiaolu Long, Qian Xu et al. · Cellular and Molecular Immunology · 2020 · 271 citations · Full text

CiRS-7 promotes growth and metastasis of esophageal squamous cell carcinoma via regulation of miR-7/HOXB13

Ruichao Li, Shun Ke, Fankai Meng et al. · Cell Death and Disease · 2018 · 215 citations · Full text

Shikonin induces glioma cell necroptosis in vitro by ROS overproduction and promoting RIP1/RIP3 necrosome formation

Bin Lü, Xu Gong, Zongqi Wang et al. · Acta Pharmacologica Sinica · 2017 · 150 citations · Full text

, , +10

RIP1 and RIP3 contribute to shikonin-induced DNA double-strand breaks in glioma cells via increase of intracellular reactive oxygen species

Zijian Zhou, Bin Lü, Chen Wang et al. · Cancer Letters · 2017 · 60 citations

, , +6

Rows per page

1–5 of 31